Condition
Insulinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Insulinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (2), China (2), Sweden (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Insulinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| A new PET/CT test to find insulinoma using a GLP-1R tracer compared to an earlier tracer | — | Beijing, Beijing Municipality | Recruiting | Sep 9, 2026 |
| EUS-guided radiofrequency ablation for pancreatic insulinoma safety and effectiveness | — | Gothenburg | Recruiting | May 13, 2026 |
| Endoscopic ultrasound-guided radiofrequency ablation for pancreatic and left adrenal lesions | — | Herlev, Capital Region | Recruiting | Dec 9, 2025 |
| Using PET/CT imaging to diagnose GLP-1 receptor related diseases | — | Hefei, Anhui and 2 other locations | Recruiting | Dec 10, 2024 |
| Using Fluorodopa F 18 to locate insulin-producing tumors in patients with congenital hyperinsulinism | Phase 1 | Fort Worth, Texas | Recruiting | Dec 27, 2013 |
| Research on diagnosing and treating low blood sugar levels | — | Bethesda, Maryland | Recruiting | Nov 4, 1999 |
All recruiting trials (6)
-
A new PET/CT test to find insulinoma using a GLP-1R tracer compared to an earlier tracer
A GLP-1 receptor–targeted PET/CT imaging agent is being tested in adults with suspected or confirmed insulinoma to see if the PEG6-modified tracer locates tumors better than the original tracer.
-
EUS-guided radiofrequency ablation for pancreatic insulinoma safety and effectiveness
This project will try EUS-guided radiofrequency ablation (EUS-RFA) to treat people with pathology-confirmed pancreatic insulinoma and compare safety and outcomes to historic surgical patients.
-
Endoscopic ultrasound-guided radiofrequency ablation for pancreatic and left adrenal lesions
This will try EUS-guided radiofrequency ablation to control symptoms and hormone-related problems in adults with small pancreatic neuroendocrine tumors (including insulinomas) or certain left adrenal adenomas.
-
Using PET/CT imaging to diagnose GLP-1 receptor related diseases
This study is testing a special imaging scan to see if it can help doctors better diagnose cancer in adults who may have diseases related to GLP-1 receptors.
-
Using Fluorodopa F 18 to locate insulin-producing tumors in patients with congenital hyperinsulinism
This study tests whether a special imaging technique using Fluorodopa F 18 can help find insulin-producing tumors in patients with congenital hyperinsulinism to improve their treatment.
-
Research on diagnosing and treating low blood sugar levels
This study is testing how to better diagnose and treat low blood sugar in people with insulinomas while they receive care at a special clinic.
Related topics
Quick answers
How many Insulinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), China (2 trials), Sweden (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.